ConductScience.org, home

Paper1120218

I alpha-hydroxycholecalciferol: a treatment of renal bone disease.

Catto GR and 3 others. Br Med J, 1975. Cited by 49 papers, by iCite.

Cite this record

ConductScience Library. I alpha-hydroxycholecalciferol: a treatment of renal bone disease. Papers, record 1120218. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1120218

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
I alpha-hydroxycholecalciferol: a treatment of renal bone disease.
PubMed
Journal
Br Med J
PubMed
Year
1975
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
49
iCite
Relative citation ratio, by iCite
2.37
iCite
Revised in PubMed
2019-05-01
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Catto GRG R
2MacLeod MM
3Pelc BB
4Kodicek EE

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bone DiseasesMajor topic
HydroxycholecalciferolsMajor topic
Kidney Failure, ChronicMajor topic
Administration, Oral
Adult
Calcium
Calcium Metabolism Disorders
Humans
Injections, Intravenous
Intestinal Absorption
Male
Middle Aged

Source PubMed

Download CSV of topics

References22

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114215559NEUTRON-ACTIVATION ANALYSIS IN MAN IN VIVO. A NEW TECHNIQUE IN MEDICAL INVESTIGATION.Lancet1964https://conductscience.org/library/papers/14215559PubMed
214072150BONE DISEASE IN CHRONIC RENAL FAILURE.Q J Med1963https://conductscience.org/library/papers/14072150PubMed
314000881A modified bone-biopsy drill for outpatient use.Lancet1963https://conductscience.org/library/papers/14000881PubMed
413721924The treatment of renal-glomerular osteodystrophy.Q J Med1961https://conductscience.org/library/papers/13721924PubMed
64578017The kidney as an endocrine organ for the production of 1,25-dihydroxyvitamin D 3 , a calcium-mobilizing hormone.N Engl J Med1973https://conductscience.org/library/papers/4578017PubMed
74704925Comparison of the stannous chloride and vanadate methods for estimation of serum inorganic phosphorus by use of the "SMA 12-60".Clin Chem1973https://conductscience.org/library/papers/4704925PubMed
84741371Partial body neutron activation analysis in vivo: a new approach to the investigation of metabolic bone disease.Phys Med Biol1973https://conductscience.org/library/papers/4741371PubMed
94111887Silver staining of bone prior to decalcification for quantitative determination of osteoid in sections.Stain Technol1972https://conductscience.org/library/papers/4111887PubMed
104623613Determination of body composition by neutron activation analysis in patient with renal failure.J Lab Clin Med1972https://conductscience.org/library/papers/4623613PubMed
114131033Effects of 1,25-dihydroxycholecalciferol on calcium absorption, muscle weakness, and bone disease in chronic renal failure.Lancet1974https://conductscience.org/library/papers/4131033PubMed
124275344Intestinal absorption of calcium and the effect of renal insufficiency.Kidney Int1973https://conductscience.org/library/papers/4275344PubMed
1341257901-Alpha-hydroxycholecalciferol as a substitute for the kidney hormone 1,25-dihydroxycholecalciferol in chronic renal failure.Lancet1973https://conductscience.org/library/papers/4125790PubMed
144121843Failure of formation of 1,25-dihydroxycholecalciferol in chronic renal insufficiency.Lancet1973https://conductscience.org/library/papers/4121843PubMed
154131034Action of 1alpha-hydroxy vitamin D3 on calcium absorption and bone resorption in man.Lancet1974https://conductscience.org/library/papers/4131034PubMed
164364427Treatment of renal osteodystrophy with calciferol (vitamin D) and related steroids.Kidney Int1973https://conductscience.org/library/papers/4364427PubMed
174333142The response of intestinal calcium transport to 25-hydroxy and 1,25-dihydroxy vitamin D in nephrectomized rats.Endocrinology1972https://conductscience.org/library/papers/4333142PubMed
184342432Action of 1,25-dihydroxycholecalciferol, a potent, kidney-produced metabolite of vitamin D3, in uremic man.N Engl J Med1972https://conductscience.org/library/papers/4342432PubMed
1943484631 -Hydroxy derivative of vitamin D 3 : a highly potent analog of 1 ,25-dihydroxyvitamin D 3 .Science1973https://conductscience.org/library/papers/4348463PubMed
204319631Unique biosynthesis by kidney of a biological active vitamin D metabolite.Nature1970https://conductscience.org/library/papers/4319631PubMed
214621774Determination of whole-body calcium by neutron activation analysis in vivo.Semin Nucl Med1972https://conductscience.org/library/papers/4621774PubMed

See all 22 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.

PMIDTitleJournalYearIn PapersSource
6307498Studies on the mode of action of vitamin D XXXVII 1 alpha-hydroxyvitamin D3: a long-acting 1,25-dihydroxyvitamin D3 analog.Calcif Tissue Int1983https://conductscience.org/library/papers/6307498PubMed
932193Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man.J Clin Invest1976https://conductscience.org/library/papers/932193PubMed
9125491alpha-Hydroxycholecalciferol in children with renal osteodystrophy.Calcif Tissue Res1977https://conductscience.org/library/papers/912549PubMed
879833Renal osteodystrophy in nondialysed adolescents. Long-term treatment with 1alpha-hydroxycholecalciferol.Arch Dis Child1977https://conductscience.org/library/papers/879833PubMed
789876Renal bone disease.J R Coll Physicians Lond1976https://conductscience.org/library/papers/789876PubMed
7826621alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in renal bone disease.Calcif Tissue Res1976https://conductscience.org/library/papers/782662PubMed
782661Comparative effect of 1alpha-hydroxycholecalciferol in children and adults with renal glomerular osteodystrophy.Calcif Tissue Res1976https://conductscience.org/library/papers/782661PubMed
334342Controlled therapeutic trial of 1alpha-hydroxycholecalciferol in chronic renal failure.Calcif Tissue Res1977https://conductscience.org/library/papers/334342PubMed
23950Therapeutic and collateral effects of 25-hydroxycholecalciferol in vitamin D deficiency.Eur J Pediatr1977https://conductscience.org/library/papers/23950PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1120218

GET https://conductscience.org/api/papers/v1/1120218/references?page=2